EMERYVILLE, Calif.,
Sept. 8, 2020 /PRNewswire/ -- Amyris,
Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in
Clean Health and Beauty markets through its consumer brands, and a
top supplier of sustainable and natural ingredients, today
announced that John Melo, President
and Chief Executive Officer, will present during the H.C.
Wainwright 22nd Annual Global Investment Virtual Conference on
Monday, September 14, 2020. The
company will also be participating in virtual one-on-one meetings
during the conference.
Amyris will provide an update on the progress and performance of
its business during the presentation, which is scheduled for
Monday, September 14, at 10:00 a.m. ET. A live webcast of the
presentation including slides and a replay will be available on the
investor relations section of the company's website at
http://investors.amyris.com. Due to the format of the virtual
conference, no audience question and answer session will be
available.
About Amyris
Amyris (Nasdaq: AMRS) is a science and
technology leader in the research, development and production of
sustainable ingredients for the Clean Health & Beauty and
Flavors & Fragrances markets. Amyris uses an impressive array
of exclusive technologies, including state-of-the-art machine
learning, robotics and artificial intelligence. Our ingredients are
included in over 3,000 products from the world's top brands,
reaching more than 200 million consumers. Amyris is proud to own
three consumer brands - all built around its No Compromise® promise
of clean ingredients: Biossance™ clean beauty skincare, Pipette™
clean baby skincare and Purecane™, a zero-calorie sweetener
naturally derived from sugarcane. For more information, please
visit www.amyris.com.
Amyris, the Amyris logo, No Compromise, Biossance, Pipette, and
Purecane are trademarks or registered trademarks of Amyris, Inc. in
the U.S. and/or other countries.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/amyris-to-present-at-hc-wainwright-22nd-annual-global-investment-conference-on-september-14-2020-301125140.html
SOURCE Amyris, Inc.